Furthermore, these A-PDK1KO metabolic changes were reversed in mice with a combined deletion of PDK1 and FoxO1 indicating that FoxO1 activity was required for the development of insulin resistance, glucose intolerance, and hepatic steatosis in mice lacking PDK1 (132). Here, PDK1 is linked to fatty liver disease.